Legacy Pharmaceutical Packaging LLC: Drug Recall
Recall #D-0205-2024 · 12/11/2023
Class II: Risk
Recall Details
- Recall Number
- D-0205-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Legacy Pharmaceutical Packaging LLC
- Status
- Ongoing
- Date Initiated
- 12/11/2023
- Location
- Earth City, MO, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 161,664 bottles
Reason for Recall
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Product Description
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54
Distribution Pattern
CA and AR
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.